Stefan Hupfeld,Tove Julie Evjen,Finn Myhren,Håvard Thøgersen
申请号：
US15118343
公开号：
US20170182073A1
申请日:
2015.02.12
申请国别(地区):
US
年份:
2017
代理人:
摘要：
Oral capsules have been dismissed as a dosage form for delivery high dosages of krill phospholipids, but by purifying these to high levels it is indeed possible to use this dosage form to deliver, for example, 700 mg or more phospholipids per capsule.
